マーケットレポート詳細
ペン型注入器(インジェクションペン)の世界市場：タイプ別、治療別2026年予測
Injection Pen Market by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care), and Region - Global Forecast to 2026
- 出版元：MarketsandMarkets
出版元について - 発行年：2021年11月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文225ページになります。
- 商品コード：MAM2732
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
ペン型注入器（インジェクションペン）の世界市場規模は2021年で376億ドル、2026年に533億ドル、市場の平均年成長率は7.2%で推移する見込みです。
ペン型注入器市場の牽引要因として、慢性疾患の有症率や規制当局による承認数の増加、有効な費用償還と政府支援、およびペン型注入器の技術的進歩などが挙げられます。
レポートはペン型注入器の世界市場について2026年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、治療別市場、等）を中心に構成されています。また競合状況、主要企業情報（18社）、バリューチェーン分析、サプライチェーン分析などの分析も加味し、ペン型注入器市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆ペン型注入器の世界市場予測2019-2026年
・市場規模(US$)
◆タイプ別、市場-2026年
・使い捨て型
・再利用型
※(市場規模US$)
◆治療別、市場-2026年
糖尿病
・インスリン
・グルカゴン様ペプチド-1(GLP-1)療法
成長ホルモン療法
骨粗鬆症
不妊
がん
自己免疫疾患
その他治療
※(市場規模US$)
◆エンドユーザー別、市場-2026年
・ホームケアセッティング
・病院/クリニック
※(市場規模US$)
◆主要国地域別市場-2026年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン、ベネルクス
・その他欧州
アジア太平洋
・日本、中国、インド、東南アジア
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（ドライバー、障壁、機会、課題）
・バリューチェーン分析
・サプライチェーン分析
・価格分析
・ファイブフォース分析
・COVID-19によるペン型注入器市場への影響
・特許分析
・市場シェア分析
・競合状況
◆ペン型注入器の主要企業プロフィール動向
・NOVO NORDISK A/S
・BECTON, DICKINSON AND COMPANY
・YPSOMED HOLDING AG
・SANOFI
・ELI LILLY AND COMPANY
・MERCK KGAA
・ASTRAZENECA
・F. HOFFMANN-LA ROCHE LTD.
・OWEN MUMFORD
・SULZER LTD.
・SUN PHARMACEUTICAL INDUSTRIES LTD.
・PFIZER
・BIOCON LTD.
・LUPIN LTD.
・WOCKHARDT LTD.
・APTARGROUP, INC.
・NOVARTIS AG
・GERRESHEIMER AG
（その他企業）
・SHAILY ENGINEERING PLASTICS LTD.
・BESPAK EUROPE LTD.
・SHL MEDICAL AG
・EMPERRA GMBH
・NEMERA FRANCE SAS
・COMPANION MEDICAL, INC.
・JIANGSU DELFU MEDICAL DEVICE CO., LTD.
（全225頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.3.3 CURRENCY
・ TABLE 1... EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1.................................................. RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
・ FIGURE 2.................................................. PRIMARY SOURCES
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
・ FIGURE 5. SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
・ FIGURE 6.......... REVENUE SHARE ANALYSIS ILLUSTRATION: SANOFI
・ FIGURE 7......... REVENUE ANALYSIS OF THE TOP FOUR COMPANIES:
INJECTION PENS MARKET (2020)
・ FIGURE 8..... CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INJECTION
PENS MARKET (2021–2026)
・ FIGURE 9................. CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
・ FIGURE 10............................................ TOP-DOWN APPROACH.. 41
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
・ FIGURE 11............. MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
・ TABLE 2.................. RISK ASSESSMENT: INJECTION PENS MARKET
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
3.... EXECUTIVE SUMMARY
・ FIGURE 12. INJECTION PENS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
・ FIGURE 13... INJECTION PENS MARKET, BY THERAPY, 2021 VS. 2026 (USD MILLION)
・ FIGURE 14..... INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2021 VS. 2026 (USD MILLION)
・ FIGURE 15. INJECTION PENS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
・ FIGURE 16....... GEOGRAPHICAL SNAPSHOT OF THE INJECTION PENS MARKET
4.... PREMIUM INSIGHTS
4.1 INJECTION PENS MARKET OVERVIEW
・ FIGURE 17 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: INJECTION PENS MARKET, BY THERAPY AND COUNTRY (2020)
・ FIGURE 18....... DIABETES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE ASIA PACIFIC INJECTION PENS MARKET IN 2020
4.3 INJECTION PENS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 19.. CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE INJECTION PENS MARKET DURING THE FORECAST PERIOD
4.4 INJECTION PENS MARKET, BY REGION, 2021–2026
・ FIGURE 20....... NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL
INJECTION PENS MARKET IN 2026
4.5 INJECTION PENS MARKET: DEVELOPED VS. DEVELOPING MARKETS
・ FIGURE 21... DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 MARKET DYNAMICS
・ FIGURE 22......... INJECTION PENS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES
5.1.1 MARKET DRIVERS
5.1.1.1 GROWING PREVALENCE OF CHRONIC DISEASES
・ FIGURE 23 NUMBER OF PEOPLE WITH CHRONIC DISEASES IN THE US,
1995–2030 (MILLION INDIVIDUALS)
・ FIGURE 24............. ESTIMATED DIABETIC POPULATION, BY REGION,
2019 VS. 2030 VS. 2040 (MILLION)
・ FIGURE 25...... GLOBAL CANCER INCIDENCE, 2015–2040 (MILLION)
5.1.1.2 INCREASING NUMBER OF REGULATORY APPROVALS
5.1.1.3 FAVORABLE REIMBURSEMENT AND GOVERNMENT SUPPORT
5.1.1.4 TECHNOLOGICAL ADVANCEMENTS IN INJECTION PENS
・ TABLE 3.............................. MARKET DRIVERS: IMPACT ANALYSIS
5.1.2 MARKET RESTRAINTS.. 57
5.1.2.1 PREFERENCE FOR ALTERNATIVE DRUG DELIVERY MODES
5.1.2.2 POOR REIMBURSEMENT SCENARIO IN DEVELOPING COUNTRIES
5.1.2.3 NEEDLE ANXIETY
・ TABLE 4......................... MARKET RESTRAINTS: IMPACT ANALYSIS
5.1.3 MARKET OPPORTUNITIES
5.1.3.1 PATENT EXPIRY OF BIOLOGICS TO DRIVE THE DEMAND FOR BIOSIMILARS.. 58
5.1.3.2 GROWTH OPPORTUNITIES IN EMERGING MARKETS
・ FIGURE 26...... DIABETES POPULATION IN DEVELOPING COUNTRIES,
2020 VS. 2040 (MILLION)
・ TABLE 5............ RISING INCOME LEVELS IN EMERGING COUNTRIES
・ TABLE 6.................... MARKET OPPORTUNITIES: IMPACT ANALYSIS
5.1.4 MARKET CHALLENGES.. 60
5.1.4.1 NEEDLESTICK INJURIES AND MISUSE OF INJECTION PENS
・ TABLE 7........................ MARKET CHALLENGES: IMPACT ANALYSIS
5.2 VALUE CHAIN ANALYSIS
・ FIGURE 27......... INJECTION PENS MARKET: VALUE CHAIN ANALYSIS
5.3 SUPPLY CHAIN ANALYSIS
・ FIGURE 28....... INJECTION PENS MARKET: SUPPLY CHAIN ANALYSIS
5.4 PRICING ANALYSIS
・ TABLE 8..... PRICING OF INJECTION PENS AVAILABLE IN THE MARKET
5.5 ECOSYSTEM MARKET MAP
・ FIGURE 29..... INJECTION PENS MARKET: ECOSYSTEM MARKET MAP
5.6 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 9 INJECTION PENS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.1 INTENSITY OF COMPETITIVE RIVALRY
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 THREAT OF NEW ENTRANTS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
・ TABLE 10.................... US FDA: MEDICAL DEVICE CLASSIFICATION
・ TABLE 11... US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.7.1.2 CANADA
・ TABLE 12......... CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
・ FIGURE 30 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
5.7.2 EUROPE
・ FIGURE 31........... EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
5.7.3 ASIA PACIFIC
5.7.3.1 JAPAN
・ TABLE 13... JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.7.3.2 CHINA
・ TABLE 14.... CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
・ TABLE 15................ CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.7.3.3 INDIA
5.8 IMPACT OF COVID-19 ON THE INJECTION PENS MARKET
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR INJECTION PENS
・ FIGURE 32............ PATENT PUBLICATION TRENDS (JANUARY 2011–SEPTEMBER 2021)
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
・ FIGURE 33................................. TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR
INJECTION PEN PATENTS (JANUARY 2011–SEPTEMBER 2021)
・ FIGURE 34.... TOP APPLICANT COUNTRIES/REGIONS FOR INJECTION PEN PATENTS (JANUARY 2011–SEPTEMBER 2021)
5.10 TECHNOLOGY ANALYSIS
・ TABLE 16................................. PEN INJECTORS CLASSIFICATION
5.10.1 KEY TECHNOLOGIES.. 76
5.10.1.1 DOSE SETTING AND NEEDLE ACTUATION
5.10.1.2 PEN INJECTOR MATERIAL
5.10.2 COMPLEMENTARY TECHNOLOGIES
5.10.2.1 IN-BUILT DOSE AND TIME LOG
5.10.2.2 WIRELESS CONNECTIVITY
5.10.2.3 SMARTPEN INJECTORS
5.10.2.4 SMART CAPS AND ATTACHMENTS
5.10.2.5 INJECTOR TEMPERATURE MONITORING
5.10.3 ADJACENT TECHNOLOGIES
5.10.3.1 AUTOINJECTORS
5.10.3.2 INSULIN PUMPS
6.... INJECTION PENS MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 17....... INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2 DISPOSABLE INJECTION PENS
6.2.1 HIGH PATIENT COMPLIANCE AND EASE OF HANDLING TO DRIVE
THE ADOPTION OF DISPOSABLE INJECTION PENS
・ TABLE 18.. DISPOSABLE INJECTION PENS AVAILABLE IN THE MARKET
・ TABLE 19....... DISPOSABLE INJECTION PENS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
6.3 REUSABLE INJECTION PENS
6.3.1 REUSABLE INJECTION PENS TO REGISTER THE HIGHEST GROWTH
DUE TO TECHNOLOGICAL ADVANCEMENTS
・ TABLE 20..... REUSABLE INJECTION PENS AVAILABLE IN THE MARKET
・ TABLE 21.......... REUSABLE INJECTION PENS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
7.... INJECTION PENS MARKET, BY THERAPY
7.1 INTRODUCTION
・ TABLE 22. INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
7.2 DIABETES
・ TABLE 23 INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 24....... INJECTION PENS MARKET FOR DIABETES THERAPY, BY COUNTRY,
2019–2026 (USD MILLION)
7.2.1 INSULIN
7.2.1.1 RISING PREVALENCE OF DIABETES IS DRIVING THE GROWTH OF THIS MARKET
・ TABLE 25......................... EXAMPLES OF INSULIN INJECTION PENS
・ TABLE 26......... INJECTION PENS MARKET FOR INSULIN THERAPY, BY COUNTRY,
2019–2026 (USD MILLION)
7.2.2 GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY
7.2.2.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE
GLP-1 DRUGS TO DRIVE MARKET GROWTH
・ TABLE 27........................... EXAMPLES OF GLP-1 INJECTION PENS
・ TABLE 28............ INJECTION PENS MARKET FOR GLP-1 THERAPY, BY COUNTRY,
2019–2026 (USD MILLION)
7.3 GROWTH HORMONE THERAPY
7.3.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN
THE MARKET GROWTH
・ TABLE 29... EXAMPLES OF INJECTION PENS FOR GROWTH HORMONE THERAPY
・ TABLE 30.......... INJECTION PENS MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 OSTEOPOROSIS
7.4.1 GROWING PREVALENCE OF OSTEOPOROSIS IN GERIATRIC PATIENTS AND WOMEN TO DRIVE MARKET GROWTH
・ TABLE 31........ EXAMPLES OF INJECTION PENS FOR OSTEOPOROSIS THERAPY
・ TABLE 32... INJECTION PENS MARKET FOR OSTEOPOROSIS THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 FERTILITY
7.5.1 DECREASE IN FERTILITY RATE HAS RESULTED IN THE INCREASED
USE OF INJECTION PENS
・ TABLE 33..... EXAMPLES OF INJECTION PENS FOR FERTILITY THERAPY
・ TABLE 34....... INJECTION PENS MARKET FOR FERTILITY THERAPY, BY COUNTRY,
2019–2026 (USD MILLION)
7.6 CANCER
7.6.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
・ TABLE 35...... EXAMPLES OF INJECTION PENS FOR CANCER THERAPY
・ TABLE 36......... INJECTION PENS MARKET FOR CANCER THERAPY, BY COUNTRY,
2019–2026 (USD MILLION)
7.7 AUTOIMMUNE DISEASES
7.7.1 DEVELOPMENTS IN THERAPIES AND DELIVERY DEVICES FOR THE TREATMENT OF MS TO BOOST THE MARKET GROWTH
・ TABLE 37. EXAMPLES OF INJECTION PENS FOR MULTIPLE SCLEROSIS AND
PSORIASIS THERAPY
・ TABLE 38...... INJECTION PENS MARKET FOR AUTOIMMUNE DISEASE THERAPY,
BY COUNTRY, 2019–2026 (USD MILLION)
7.8 OTHER THERAPIES
・ TABLE 39........ INJECTION PENS MARKET FOR OTHER THERAPIES, BY COUNTRY,
2019–2026 (USD MILLION)
8.... INJECTION PENS MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 40 INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOME CARE SETTINGS
8.2.1 HOME CARE SETTINGS ARE THE LARGEST END USERS OF INJECTION PENS
・ TABLE 41... INJECTION PENS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2019–2026 (USD MILLION)
8.3 HOSPITALS & CLINICS
8.3.1 GROWING INCIDENCE OF NEEDLESTICK INJURIES AND UNSAFE INJECTION PRACTICES HAVE INCREASED THE DEMAND FOR INJECTION PENS
・ TABLE 42... INJECTION PENS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2019–2026 (USD MILLION)
9.... INJECTION PENS MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 43... INJECTION PENS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ FIGURE 35....... EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH
IN THE FORECAST PERIOD
9.2 NORTH AMERICA
・ FIGURE 36... NORTH AMERICA: INJECTION PENS MARKET SNAPSHOT
・ TABLE 44. INJECTION PENS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 45........ NORTH AMERICA: INJECTION PENS MARKET, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 46.. NORTH AMERICA: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 47 NORTH AMERICA: INJECTION PENS MARKET FOR DIABETES THERAPY,
BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 48 NORTH AMERICA: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 THE US DOMINATES THE NORTH AMERICAN INJECTION PENS MARKET
・ FIGURE 37...... TOTAL FERTILITY RATE IN THE US POPULATION (1990-2020)
・ TABLE 49....................................... US: KEY MACROINDICATORS
・ TABLE 50.. US: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 51... US: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 52. US: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 53.. US: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 UNFAVORABLE REGULATORY PROCESSES IN CANADA TO RESTRAIN
THE MARKET GROWTH
・ TABLE 54............................... CANADA: KEY MACROINDICATORS
・ TABLE 55.. CANADA: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 56............. CANADA: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 57........... CANADA: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 58........... CANADA: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3 EUROPE
・ TABLE 59............ EUROPE: INJECTION PENS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 60.. EUROPE: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 61............. EUROPE: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 62........... EUROPE: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 63........... EUROPE: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 HIGH DIABETES EXPENDITURE AND REIMBURSEMENT FOR INJECTION PENS TO DRIVE THE MARKET IN GERMANY
・ TABLE 64............................. GERMANY: KEY MACROINDICATORS
・ TABLE 65 GERMANY: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 66........... GERMANY: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 67......... GERMANY: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 68......... GERMANY: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 MISUSE OF INJECTION PENS POSE A THREAT TO THE GROWTH OF THIS MARKET
・ TABLE 69................................ FRANCE: KEY MACROINDICATORS
・ TABLE 70.. FRANCE: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 71............. FRANCE: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 72........... FRANCE: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 73............ FRANCE: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.3 UK
9.3.3.1 NHS SUPPORT AND ACCESS TO COST-EFFECTIVE INJECTION PENS ARE LIKELY TO DRIVE THE MARKET IN THE UK
・ TABLE 74....................................... UK: KEY MACROINDICATORS
・ TABLE 75.. UK: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 76... UK: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 77. UK: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 78.. UK: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 REGIONAL VARIATION IN TERMS OF COVERAGE AND BENEFITS TO HINDER THE MARKET GROWTH
・ TABLE 79.................................... ITALY: KEY MACROINDICATORS
・ TABLE 80...... ITALY: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 81 ITALY: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 82.. ITALY: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 83...... ITALY: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 SUPPORTIVE REGULATIONS MANDATING THE USE OF SAFETY INJECTION PENS TO BOOST THE GROWTH OF THE SPANISH MARKET
・ TABLE 84.................................. SPAIN: KEY MACROINDICATORS
・ TABLE 85..... SPAIN: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 86 SPAIN: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 87. SPAIN: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 88..... SPAIN: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 BENELUX
9.3.6.1 INCREASING AWARENESS ABOUT INJECTION PEN DEVICES TO
DRIVE MARKET GROWTH
・ TABLE 89. BENELUX: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 90............ BENELUX: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 91.......... BENELUX: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 92.......... BENELUX: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.3.7 REST OF EUROPE
・ TABLE 93 ROE: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 94.. ROE: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 95 ROE: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 96 ROE: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
・ FIGURE 38....... ASIA PACIFIC: INJECTION PENS MARKET SNAPSHOT
・ TABLE 97 APAC: INJECTION PENS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 98...... APAC: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 99 APAC: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 100 APAC: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 101.... APAC: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 HIGH DIABETES INCIDENCE AND SUPPORTIVE REIMBURSEMENT POLICIES TO DRIVE THE MARKET GROWTH IN JAPAN
・ TABLE 102................................ JAPAN: KEY MACROINDICATORS
・ TABLE 103... JAPAN: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 104.... JAPAN: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 105 JAPAN: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 106... JAPAN: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 LARGE PATIENT POPULATION AND HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO DRIVE THE MARKET GROWTH IN CHINA
・ TABLE 107................................ CHINA: KEY MACROINDICATORS
・ TABLE 108... CHINA: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 109.... CHINA: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 110 CHINA: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 111... CHINA: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 RISING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH
・ TABLE 112................................. INDIA: KEY MACROINDICATORS
・ TABLE 113.... INDIA: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 114..... INDIA: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 115 INDIA: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 116... INDIA: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 SOUTHEAST ASIA
9.4.4.1 GROWING AWARENESS ABOUT DIABETES TO DRIVE THE ADOPTION OF
INJECTION PENS
・ FIGURE 39....... DIABETES PREVALENCE IN SOUTHEAST ASIA (2019)
・ FIGURE 40... HEALTHCARE EXPENDITURE (% OF GDP) IN SOUTHEAST ASIA (2018)
・ FIGURE 41. GERIATRIC POPULATION (% OF THE TOTAL POPULATION), 2019
・ TABLE 117...... SOUTHEAST ASIA: INJECTION PENS MARKET, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 118 SOUTHEAST ASIA: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 119............ SOUTHEAST ASIA: INJECTION PENS MARKET FOR DIABETES THERAPY,
BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 120....... SOUTHEAST ASIA: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.4.5 REST OF APAC
・ TABLE 121 ROAPAC: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 122........... ROAPAC: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 123......... ROAPAC: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 124......... ROAPAC: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.5 LATIN AMERICA
・ TABLE 125... LATAM: INJECTION PENS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 126.. LATAM: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 127.... LATAM: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 128............ LATAM: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 129............ LATAM: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 BRAZIL DOMINATES THE INJECTION PENS MARKET IN LATIN AMERICA
・ TABLE 130............................... BRAZIL: KEY MACROINDICATORS
・ TABLE 131.. BRAZIL: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 132... BRAZIL: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 133........... BRAZIL: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 134........... BRAZIL: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 INCREASING INCIDENCE OF LIFESTYLE-RELATED DISORDERS TO DRIVE
MARKET GROWTH IN MEXICO
・ TABLE 135.............................. MEXICO: KEY MACROINDICATORS
・ TABLE 136. MEXICO: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 137.. MEXICO: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 138.......... MEXICO: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 139.......... MEXICO: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
・ FIGURE 42.... HEALTH EXPENDITURE (% OF GDP) IN LATIN AMERICAN COUNTRIES, 2018
・ TABLE 140...... ROLATAM: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 141......... ROLATAM: INJECTION PENS MARKET, BY THERAPY,
2019–2026 (USD MILLION)
・ TABLE 142........ ROLATAM: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 143........ ROLATAM: INJECTION PENS MARKET, BY END USER,
2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY TO
SUPPORT MARKET GROWTH
・ TABLE 144..... MEA: INJECTION PENS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 145 MEA: INJECTION PENS MARKET, BY THERAPY, 2019–2026 (USD MILLION)
・ TABLE 146. MEA: INJECTION PENS MARKET FOR DIABETES THERAPY, BY TYPE,
2019–2026 (USD MILLION)
・ TABLE 147..... MEA: INJECTION PENS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.. COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
・ FIGURE 43............ REVENUE ANALYSIS OF THE TOP PLAYERS IN THE INJECTION PENS MARKET
10.4 MARKET SHARE ANALYSIS
・ FIGURE 44........ INJECTION PENS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.5 MARKET RANKING ANALYSIS OF OEM COMPANIES
・ FIGURE 45... INJECTION PENS MARKET RANKING, BY OEM COMPANY (2020)
10.6 COMPANY EVALUATION QUADRANT
10.6.1 STARS
10.6.2 EMERGING LEADERS.. 166
10.6.3 PERVASIVE PLAYERS.. 166
10.6.4 PARTICIPANTS
・ FIGURE 46......... INJECTION PENS MARKET: COMPANY EVALUATION QUADRANT (2020)
10.7 COMPANY EVALUATION QUADRANT FOR START-UPS
10.7.1 PROGRESSIVE COMPANIES
10.7.2 DYNAMIC COMPANIES.. 168
10.7.3 STARTING BLOCKS.. 168
10.7.4 RESPONSIVE COMPANIES
・ FIGURE 47......... INJECTION PENS MARKET: COMPANY EVALUATION QUADRANT
FOR START-UPS (2020)
10.8 COMPANY PRODUCT FOOTPRINT
・ TABLE 148.......... PRODUCT PORTFOLIO ANALYSIS: INJECTION PENS MARKET, BY TYPE
・ TABLE 149.......... PRODUCT PORTFOLIO ANALYSIS: INJECTION PENS MARKET, BY THERAPY
10.9 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE INJECTION PENS MARKET
・ TABLE 150.... GEOGRAPHIC REVENUE MIX: INJECTION PENS MARKET (2020)
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES
・ TABLE 151 PRODUCT LAUNCHES (JANUARY 2018–SEPTEMBER 2021)
10.10.2 OTHER DEVELOPMENTS
・ TABLE 152.... OTHER DEVELOPMENTS (JANUARY 2018–SEPTEMBER 2021)
11.. COMPANY PROFILES
11.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW)*
11.1.1 NOVO NORDISK A/S.. 176
・ TABLE 153................... NOVO NORDISK A/S: BUSINESS OVERVIEW
・ FIGURE 48........ NOVO NORDISK A/S: COMPANY SNAPSHOT (2020)
11.1.2 BECTON, DICKINSON AND COMPANY
・ TABLE 154............ BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・ FIGURE 49............ BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.3 YPSOMED HOLDING AG
・ TABLE 155............... YPSOMED HOLDING AG: BUSINESS OVERVIEW
・ FIGURE 50.... YPSOMED HOLDING AG: COMPANY SNAPSHOT (2020)
11.1.4 SANOFI
・ TABLE 156................................... SANOFI: BUSINESS OVERVIEW
・ FIGURE 51......................... SANOFI: COMPANY SNAPSHOT (2020)
11.1.5 ELI LILLY AND COMPANY
・ TABLE 157............. ELI LILLY AND COMPANY: BUSINESS OVERVIEW
・ FIGURE 52... ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.6 MERCK KGAA
・ TABLE 158........................... MERCK KGAA: BUSINESS OVERVIEW
・ FIGURE 53................. MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.7 ASTRAZENECA
・ TABLE 159.......................... ASTRAZENECA: BUSINESS OVERVIEW
・ FIGURE 54................ ASTRAZENECA: COMPANY SNAPSHOT (2020)
11.1.8 F. HOFFMANN-LA ROCHE LTD.
・ TABLE 160...... F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・ FIGURE 55...... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
11.1.9 OWEN MUMFORD
・ TABLE 161...................... OWEN MUMFORD: BUSINESS OVERVIEW
11.1.10 SULZER LTD.
・ TABLE 162............................ SULZER LTD.: BUSINESS OVERVIEW
11.1.11 SUN PHARMACEUTICAL INDUSTRIES LTD.
・ TABLE 163....... SUN PHARMACEUTICAL INDUSTRIES LTD: BUSINESS OVERVIEW
・ FIGURE 56...... SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2020)
11.1.12 PFIZER
・ TABLE 164.................................... PFIZER: BUSINESS OVERVIEW
・ FIGURE 57......................... PFIZER: COMPANY SNAPSHOT (2020)
11.1.13 BIOCON LTD.
・ TABLE 165............................ BIOCON LTD.: BUSINESS OVERVIEW
・ FIGURE 58.................. BIOCON LTD.: COMPANY SNAPSHOT (2020)
11.1.14 LUPIN LTD.
・ TABLE 166............................... LUPIN LTD.: BUSINESS OVERVIEW
・ FIGURE 59.................... LUPIN LTD.: COMPANY SNAPSHOT (2020)
11.1.15 WOCKHARDT LTD.
・ TABLE 167...................... WOCKHARDT LTD.: BUSINESS OVERVIEW
・ FIGURE 60........... WOCKHARDT LTD.: COMPANY SNAPSHOT (2020)
11.1.16 APTARGROUP, INC.
・ TABLE 168.................... APTARGROUP, INC.: BUSINESS OVERVIEW
・ FIGURE 61.......... APTARGROUP, INC.: COMPANY SNAPSHOT (2020)
11.1.17 NOVARTIS AG
・ TABLE 169........................... NOVARTIS AG: BUSINESS OVERVIEW
・ FIGURE 62................. NOVARTIS AG: COMPANY SNAPSHOT (2020)
11.1.18 GERRESHEIMER AG
・ TABLE 170................... GERRESHEIMER AG: BUSINESS OVERVIEW
・ FIGURE 63......... GERRESHEIMER AG: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 SHAILY ENGINEERING PLASTICS LTD.
・ TABLE 171............ SHAILY ENGINEERING PLASTICS LTD.: BUSINESS OVERVIEW
11.2.2 BESPAK EUROPE LTD.
・ TABLE 172................. BESPAK EUROPE LTD.: BUSINESS OVERVIEW
11.2.3 SHL MEDICAL AG
・ TABLE 173....................... SHL MEDICAL AG: BUSINESS OVERVIEW
11.2.4 EMPERRA GMBH
・ TABLE 174....................... EMPERRA GMBH: BUSINESS OVERVIEW
11.2.5 NEMERA FRANCE SAS.. 220
・ TABLE 175................ NEMERA FRANCE SAS: BUSINESS OVERVIEW
11.2.6 COMPANION MEDICAL, INC.
・ TABLE 176......... COMPANION MEDICAL, INC.: BUSINESS OVERVIEW
11.2.7 JIANGSU DELFU MEDICAL DEVICE CO., LTD.
・ TABLE 177.... JIANGSU DELFU MEDICAL DEVICE CO., LTD.: BUSINESS OVERVIEW
* BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.. APPENDIX